Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v5-FR
Language English French
Date Updated 2023-05-27 2023-04-21
Drug Identification Number 02512424 02512424
Brand name BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
Common or Proper name Bupivacaine Hydrochloride In Dextrose Injection USP Bupivacaine Hydrochloride In Dextrose Injection USP
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients BUPIVACAINE HYDROCHLORIDE BUPIVACAINE HYDROCHLORIDE
Strength(s) 7.5MG 7.5MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRASPINAL INTRASPINAL
Packaging size 10 x 2 mL vial / fiole 10 x 2 mL vial / fiole
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2023-04-14 2023-04-14
Estimated end date 2023-05-26 2023-05-26
Actual end date 2023-05-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product not available at Guelph warehouse. Product available at CPDN Vaughan.
Health Canada comments